Woodside Energy is rated a Buy as it approaches a harvesting phase with key projects like Scarborough (96% complete), Trion (56% complete), and Louisiana LNG progressing well. Despite a Q1 revenue beat amid lower volumes, the company's valuation suggests it remains undervalued compared to its intrinsic value. Speculation about a potential Exxon acquisition is viewed skeptically unless a significant premium is offered, as Woodside offers better standalone value with expected stronger cash flow and higher shareholder returns ahead.
Harvest Investment Services has sold 356,000 shares of Adaptive Biotechnologies, totaling approximately $5.7 million. This significant sale may impact the stock's market perception and price. Investors should watch for any further moves by major shar...
EigenCloud's Total Value Locked (TVL) surged by $291 million in one week to $4.67 billion, signaling increased investor commitment despite a drop in token holders. Positive net capital inflow and bullish trader activity, reflected by a Long-to-Short ...
Hasbro continues to be a strong buy due to the growth driven by its Wizards of the Coast division, particularly through Magic: The Gathering. The expansion of Magic's ecosystem, record sales, and growth in backlist and Secret Lair products support a ...
XRP's price rebounded to around $1.18 after earlier weakness, driven by expanding use in payments, tokenization, liquidity, and settlement. Industry experts highlight that the XRP Ledger's growing utility, including Ripple's cross-border payments and...
Crinetics Pharmaceuticals presented positive Phase 2 trial results for atumelnant, an oral ACTH receptor antagonist, showing it effectively lowers androgen levels and allows reduction of glucocorticoid doses in adults with classic congenital adrenal ...
